|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "ABORTION".
An abortion is the removal or expulsion of an embryo or fetus
from the uterus, resulting in or caused by its death. This can occur
spontaneously as a miscarriage, or be artificially induced by
chemical, surgical or other means. Commonly, "abortion" refers to
an induced procedure at any point during pregnancy; medically, it is
defined as miscarriage or induced termination before twenty weeks'
gestation, which is considered nonviable. |
|
|
| Complete, early abortion with misoprostol. [Aborto temprano y completo con |
| Reproductive Health Matters. 2001 Nov;9(18):190. |
| The drug misoprostol (Cytotec) has been used to induce medical abortion both alone and in combination with |
| mifepristone. Misoprostol is inexpensive, already licensed in many countries as a treatment for stomach ulcers and |
| does not need to be refrigerated. Studies are ongoing in an effort to refine the dosage, to increase rates of complete |
| abortion in early pregnancy and decrease side effects, e.g., vaginal insertion of misoprostol has been tested for |
| doses ranging between 200 and 800 mcg. In this trial, conducted in Cuba, the dosage used was 1000 mcg, in order |
| to increase the strength of uterine contractions. 300 women between 42 and 63 days of pregnancy who wanted to |
| terminate their pregnancies were trained to insert 5 200-mcg tablets of misoprostol into the vagina. They were also |
| given medication to alleviate the side effects of nausea, pelvic pain, cramping, and diarrhea. If abortion had not |
| occurred after 24 hours, the women repeated the regimen. If abortion still did not occur, the regimen was repeated |
| again 24 hours later. All women who aborted then received an additional dose of 600 mcg of misoprostol vaginally |
| 24 hours after ultrasound confirmation that abortion had occurred, to ensure complete yterine evacuation. Complete |
| abortion occurred in 93% of cases. With 1000 mcg of misoprostol cramping began after 3 hours, bleeding at 5 |
| hours, and expulsion at 8 hours. A post study questionnaire showed that the majority of women felt positively about |
| the procedure and 94% said they would use the procedure again in future if the need arose. Although side effects |
| such as pain and nausea were common, they could be alleviated with medication. This regimen of misoprostol |
| seems acceptable and effective for early termination of pregnancy. (PubHealth.info Document ID: ABOR1T 894-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Complete, early abortion with misoprostol. [Aborto |
| temprano y completo con misoprostol.]", is(are) . The source of this article is "Reproductive Health Matters. 2001 |
| Nov;9(18):190.". This article was published in 2001 in English language(s). (PubHealth.info® Document ID: ABOR1T |
| 894-06. All rights reserved with PubHealth.info) PIN: 894 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |
